Abstract: Systems and methods for producing ammonia are described. In one embodiment, hydrogen, carbon dioxide, and nitrogen are dissolved in a solution. A glutamine synthetase inhibitor and autotrophic diazotroph bacteria are also placed in the solution.

Abstract: The present disclosure relates generally to compounds that are inhibitors of CD73 and are useful in treating CD73-associated diseases or conditions. Compositions containing the compounds of the present disclosure are also provided.

Abstract: Disclosed are compounds that arc inhibitors of CD73 and arc useful in treating CD73-associated diseases or conditions, and compositions containing the compounds.

Abstract: Methods, computer program products, and/or systems are provided that perform the following operations: obtaining a series of indicator diagrams corresponding to strokes of a pumpjack over a specific time duration, dividing each indicator diagram into a plurality of location segments in a direction of location of the rod; obtaining load difference features between upstroke loads and corresponding downstroke loads in the plurality of location segments; identifying a location segment with an abnormal load difference feature based on a time series data of load difference feature corresponding to one of the plurality of location segments, the time series data of load difference feature including a series of data points of load difference feature of the one of the plurality of location segments in time order; and providing an indication of a potential problem based, at least in part, on the identification of the location segment with an abnormal load difference feature.

Abstract: Compounds of Formula I, as shown below and defined herein: and pharmaceutically acceptable salts, syntheses, intermediates, formulations, and methods of treating diseases including cancer, inflammation, and autoimmune disease mediated at least in part by Bruton's Tyrosine Kinase (BTK).

Abstract: A water sterilization device includes: (1) a conduit; (2) a first porous electrode housed in the conduit; (3) a second porous electrode housed in the conduit and disposed adjacent to the first porous electrode; and (4) an electrical source coupled to the first porous electrode and the second porous electrode to apply a voltage difference between the first porous electrode and the second porous electrode. The conduit is configured to provide passage of a fluid stream through the first porous electrode and the second porous electrode, and an inactivation efficiency of pathogens in the fluid stream is at least about 99%, such as at least about 99.9% or at least about 99.95%.

Abstract: Disclosed is a new drug application of a Pithecellobium Clypearia Benth Extract (EA), and particularly is a method of the EA used for treating multiple diseases caused by drug resistant bacteria infection. Related drug resistant bacteria include a Multi-Drug Resistant (MDR) Acinetobacter Baumannii (MDRAB), an MDR Pseudomonas Aeruginosa (MDRPA), an Extended-Spectrum Beta-Lactamase (ESBL) producing Escherichia Coli (ECO) and an ESBL-producing Klebsiella Pneumonia (KPN).

Abstract: Disclosed is a new drug application of a Pithecellobium clypearia Benth Extract (EA), and particularly is a method of the EA used for treating multiple diseases caused by drug resistant bacteria infection. Related drug resistant bacteria include a Multi-Drug Resistant (MDR) Acinetobacter baumannii (MDRAB), an MDR Pseudomonas aeruginosa (MDRPA), an Extended-Spectrum Beta-Lactamase (ESBL) producing Escherichia coli (ECO) and an ESBL-producing Klebsiella pneumonia (KPN).

Abstract: Multiple data paths may be available to a data management system for transferring data between a primary storage device and a secondary storage device. The data management system may be able to gain operational advantages by performing load balancing across the multiple data paths. The system may use application layer characteristics of the data for transferring from a primary storage to a backup storage during data backup operation, and correspondingly from a secondary or backup storage system to a primary storage system during restoration.

Abstract: The present invention provides a method, computer system and computer program product for generating a defect description. According to the method, one or more keywords from a user for depicting a defect encountered when using a software product are received. A search for one or more terms matching at least one of the keywords and a path corresponding to the one or more terms in an operation map is conducted, wherein the operation map includes terms and paths describing all possible operations of a software product based on a user interface of the software product. And in response to the one or more terms matching the at least one of the keywords and a corresponding path are searched out, a defect description based on the one or more matched terms, the corresponding path and the received keywords is generated.

Abstract: Disclosed is a new drug application of a Pithecellobium Clypearia Benth Extract (EA), and particularly is a method of the EA used for treating multiple diseases caused by drug resistant bacteria infection. Related drug resistant bacteria include a Multi-Drug Resistant (MDR) Acinetobacter Baumannii (MDRAB), an MDR Pseudomonas Aeruginosa (MDRPA), an Extended-Spectrum Beta-Lactamase (ESBL) producing Escherichia Coli (ECO) and an ESBL-producing Klebsiella Pneumonia (KPN).

Abstract: Multiple data paths may be available to a data management system for transferring data between a primary storage device and a secondary storage device. The data management system may be able to gain operational advantages by performing load balancing across the multiple data paths. The system may use application layer characteristics of the data for transferring from a primary storage to a backup storage during data backup operation, and correspondingly from a secondary or backup storage system to a primary storage system during restoration.

Abstract: Systems and methods for fixing carbon using bacteria are described. In one embodiment, a system includes a reactor chamber with a solution contained therein. The solution may include hydrogen (H2), carbon dioxide (CO2), bioavailable nitrogen, and a chemolithoautotrophic bacteria. The system may also include a pair of electrodes that split water contained within the solution to form the hydrogen. Additionally, the system may be operated so that a concentration of the bioavailable nitrogen in the solution is below a threshold nitrogen concentration to cause the chemolithoautotrophic bacteria to produce a product.

Abstract: A lower limb exoskeleton system includes a back frame, hip joint movement mechanisms, telescopic thigh bars, knee joint movement mechanisms, shank bars, foot jump-down cushioning mechanisms, a waist binding frame, upper leg binding frames and lower leg binding frames. Two protruding ends of the back frame are connected with a top end of each of the telescopic thigh bars respectively via the hip joint movement mechanisms, bottom ends of the telescopic thigh bars are connected with a top end of the corresponding shank bars respectively via the knee joint movement mechanisms, and bottom ends of the shank bars are connected with the foot jump-down cushioning mechanisms. The waist binding frame is arranged on an inner side of a horizontal part of the back frame, and the upper leg binding frames and the lower leg binding frames are arranged on the telescopic thigh bars and the shank bars respectively.

Abstract: A semiconductor device and a method of fabricating the device are disclosed. The method of forming a metal layer includes: placing a substrate in a sputtering chamber; forming a first metal sub-layer on the substrate by performing a magnetron sputtering process; and forming a second metal sub-layer on the first metal sub-layer by performing another magnetron sputtering process and concurrently introducing a heated gas stream in the sputtering chamber, wherein the first metal sub-layer and the second metal sub-layer together constitute the metal layer and are each formed of aluminum doped with copper. The metal layer resulting from this method contains uniformly-sized small crystal grains separated from one another by minimal gaps between their grain boundaries. This imparts to the metal layer high surface flatness with fewer undesired bumps and hence good appearance, resulting in an increase in its yield.

Abstract: This disclosure provides systems, methods, and apparatus related to nanostructures. In one aspect, an array of nanowires is provided. The array of nanowires comprises a plurality of nanowires. End of nanowires of the plurality of nanowires are attached to a substrate. A liquid including a plurality of nanoparticles is deposited on the array of nanowires. The liquid is evaporated from the array of nanowires. Nanoparticles of the plurality of nanoparticles are deposited on the nanowires as a meniscus of the liquid recedes along lengths of the plurality of nanowires.

Abstract: A method for extracting metal ions from water is provided that includes disposing two electrically conductive electrodes in water, where the water includes a target ion species in solution, where at least one of the electrically conductive electrodes is a functionalized electrode having species-specific adsorption of the target ion species, and providing electrical current to the electrically conductive electrodes such that the one or more target ion species are deposited to metallic form or metal oxides at the functionalized electrode by one or more electrochemical reactions.

Abstract: Disclosed is a new drug application of a Pithecellobium clypearia Benth Extract (EA), and particularly is a method of the EA used for treating multiple diseases caused by drug resistant bacteria infection. Related drug resistant bacteria include a Multi-Drug Resistant (MDR) Acinetobacter baumannii (MDRAB), an MDR Pseudomonas aeruginosa (MDRPA), an Extended-Spectrum Beta-Lactamase (ESBL) producing Escherichia coli (ECO) and an ESBL-producing Klebsiella pneumonia (KPN).

Abstract: Disclosed is a new drug application of a Pithecellobium clypearia Benth Extract (EA), and particularly is a method of the EA used for treating multiple diseases caused by drug resistant bacteria infection. Related drug resistant bacteria include a Multi-Drug Resistant (MDR) Acinetobacter baumannii (MDRAB), an MDR Pseudomonas aeruginosa (MDRPA), an Extended-Spectrum Beta-Lactamase (ESBL) producing Escherichia coli (ECO) and an ESBL-producing Klebsiella pneumonia (KPN).

Abstract: Disclosed is a new drug application of a Pithecellobium clypearia Benth Extract (EA), and particularly is a method of the EA used for treating multiple diseases caused by drug resistant bacteria infection. Related drug resistant bacteria include a Multi-Drug Resistant (MDR) Acinetobacter baumannii (MDRAB), an MDR Pseudomonas aeruginosa (MDRPA), an Extended-Spectrum Beta-Lactamase (ESBL) producing Escherichia coli (ECO) and an ESBL-producing Klebsiella pneumonia (KPN).